List view / Grid view

Immunooncology

 

article

Antibodies In-Depth Focus 2017

15 March 2017 | By

Lone Friis and David Matthews discuss developability assessment of therapeutic antibodies, and Negin Mokhtari and colleagues explain nanoparticle-mediated enzyme delivery for application in cancer therapy...

news

Targovax appoints of Øystein Soug as CEO

4 November 2016 | By Niamh Louise Marriott, Digital Content Producer

Øystein Soug is the former CFO of Algeta, a Norwegian oncology biotech company which was sold to Bayer for USD 2.9 billion in 2014...